Few Surgeon-Scientists Continue to Receive NIH Funding After Training
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, July 17, 2023 -- Surgery trainees who obtain National Institutes of Health (NIH) F32 grants during training are less likely to receive any form of NIH funding in the future compared with internal medicine colleagues receiving F32 grants, according to a study published online June 26 in the Annals of Surgery.
Adishesh K. Narahari, Ph.D., from the University of Virginia School of Medicine in Charlottesville, and colleagues examined trainees in surgery and internal medicine who received NIH F32 postdoctoral awards to determine their success rates in obtaining future NIH funding. The analysis included NIH F32 grants (1992 to 2021) identified from the NIH RePORTER database.
The researchers found that 269 surgeons and 735 internal medicine trainees received F32 grants, with 17.8 percent of the surgeons and 50.2 percent of the internal medicine trainees receiving future NIH funding. Future R01 grants were received by 8.9 percent of surgeons and 19.7 percent of internal medicine trainees. Additionally, surgeons who received F32 grants were more likely to be department chairs or division chiefs.
"We hope this paper sparks a movement to encourage the development of surgeon-scientists through curricular, programmatic, and supportive mechanisms that foster those highly interested in such career paths to be most productive and successful," a coauthor said in a statement. "We hope those who oversee surgical education and training will strongly consider these findings."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis
TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of...
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.